Acute XXXX treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography.

@entity1 @entity583 @entity551 @entity1455
The Society for Cardiac Angiography maintains a registry of intracoronary streptokinase therapy (IC-SK) in @entity1 with @entity583 . Between July 1981 and August 1984, 1,029 @entity1 were entered into the registry. The baseline and clinical characteristics of @entity1 were determined, the early results of therapy were evaluated, and baseline characteristics of those in whom reperfusion was achieved were compared with those in whom it was not. Multivariate discriminant analysis was used to identify the predictors of reperfusion and hospital mortality. The overall rate of reperfusion was 71.2%. Reperfusion was positively associated with @entity551 , @entity1455 and early treatment. The hospital mortality rate for all @entity1 was 8.2% and was higher for @entity1 and the elderly. The hospital mortality was significantly lower among @entity1 in whom reperfusion was achieved compared with those in whom it was not (5.5% vs 14.7%, p less than 0.0001) and for several high-risk subgroups. Thus, coronary artery reperfusion induced by IC-SK significantly reduces hospital mortality in high-risk @entity1 with @entity583 . High-risk @entity1 in whom reperfusion fails with IC-SK therapy should be considered for early coronary angioplasty or coronary artery bypass surgery.
